Coeptis Therapeutics Holdings, Inc.

Ownership Transactions Reported by 13 Insiders

Symbol
COEP, COEPW on Nasdaq
Location
105 Bradford Road, Suite 420, Wexford, Pennsylvania

Insiders trading volume in the past year

Coeptis Therapeutics Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
David Mehalick CEO and President, Director, 10%+ Owner $1.61 M +$16.7 K +1.05% Jan 5, 2024
Chris Calise Director $850 K +$10.9 K +1.3% Aug 23, 2023
Daniel A. Yerace VP of Operations, Director $621 K +$7.49 K +1.22% Jan 5, 2024
Glazer Capital, Llc 10%+ Owner $559 K May 25, 2021
Harraden Circle Investments, LLC 10%+ Owner $249 K May 4, 2022
Gene Salkind Director $167 K +$38.1 K +29.5% Jan 5, 2024
Christopher P. Cochran Director $21.5 K +$5.39 K +33.5% Jan 5, 2024
Tara DeSilva Director $18.7 K +$1.31 K +7.5% Jan 12, 2024
Brian Cogley Chief Financial Officer $17.4 K +$3.35 K +23.8% Jan 10, 2024
Barclays Plc 10%+ Owner Nov 5, 2021
Bull Horn Holdings Sponsor LLC 10%+ Owner Oct 28, 2022
Philippe Deschamps Director Jan 27, 2023
Christine E. Sheehy CFO and Secretary, Director Jan 27, 2023

Recent Insider Transactions by Companies or Individuals for Coeptis Therapeutics Holdings, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership